| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 26/10/2021 | 12h59 | Business Wire | Crestwood to Acquire Oasis Midstream Partners in $1.8 Billion Transaction | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 25/04/2013 | 14h00 | PR Newswire (US) | Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc. | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 24/04/2013 | 14h00 | PR Newswire (US) | Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 23/04/2013 | 14h00 | PR Newswire (US) | Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstand... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 22/04/2013 | 14h00 | PR Newswire (US) | Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisitio... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 17/04/2013 | 22h28 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 12/04/2013 | 23h30 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 12/04/2013 | 23h17 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 12/04/2013 | 23h17 | Edgar (US Regulatory) | Post-effective Amendment (investment Company, Rule 485(a)) (485apos) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 09/04/2013 | 16h43 | Zacks | Valeant: The Sole Suitor for Obagi - Analyst Blog | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 08/04/2013 | 15h20 | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 08/04/2013 | 14h22 | Dow Jones News | Merz Pharma Withdraws Offer for Obagi Medical After Valeant's Sweetened Bid | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 08/04/2013 | 13h32 | PR Newswire (US) | Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 05/04/2013 | 22h56 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 05/04/2013 | 22h49 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/04/2013 | 23h20 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/04/2013 | 19h50 | Zacks | Valeant Ups Offer for Obagi - Analyst Blog | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/04/2013 | 12h02 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 23h19 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 20h51 | GlobeNewswire Inc. | CORRECTING and REPLACING -- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 19h47 | GlobeNewswire Inc. | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Obagi Medic | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 17h26 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 15h13 | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 15h02 | Dow Jones News | Valeant Boosts Price for Obagi to $420 Million, Besting Merz Offer | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 14h00 | PR Newswire (US) | Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 14h00 | Business Wire | Obagi Medical Products, Inc. and Valeant Pharmaceuticals, Inc. Agree on an Increased Offer Price of $24.00 per Share in Cash | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 02/04/2013 | 23h18 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 02/04/2013 | 22h22 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 02/04/2013 | 19h42 | Dow Jones News | UPDATE: Merz Pharma Offers to Buy Obagi, Looks to Top Valeant Deal | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 02/04/2013 | 18h30 | Business Wire | Board of Directors of Obagi Medical Products, Inc. Receives Unsolicited Acquisition Proposal from Merz Pharma | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |